Mitochondrial dysfunction in autism

Seminars in Pediatric Neurology

Volumn 20, Issue 3, 2013, Pages 163-175

  Legido, Agustín ^a,b   Jethva, Reena ^a,b   Goldenthal, Michael J ^a,b  

^a ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CARNITINE; CELL NUCLEUS DNA; LACTIC ACID; MITOCHONDRIAL DNA; PURINERGIC RECEPTOR; PYRUVIC ACID;

ARTICLE; AUTISM; CALCIUM TRANSPORT; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG TARGETING; EPIGENETICS; FATTY ACID OXIDATION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL GENE; MOLECULAR PATHOLOGY; NEUROPATHOLOGY; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; RESPIRATORY CHAIN; SIGNAL TRANSDUCTION;

AUTISTIC DISORDER; BRAIN; DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIAL DISEASES; MODELS, NEUROLOGICAL; MUTATION;

EID: 84890208043     PISSN: 10719091     EISSN: 15580776     Source Type: Journal    
DOI: 10.1016/j.spen.2013.10.008     Document Type: Article

References (112)

1. Ducham E., Patel D.R. Epidemiology of autism spectrum disorders. Pediatr Clin North Am 2012, 59:27-43.
2. Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Association, American Psychiatric Publishing, Washington, DC. 5th ed.
3. Nazeer A., Ghaziuddin M. Autism spectrum disorders: Clinical features and diagnosis. Pediatr Clin North Am 2012, 59:19-25.
4. Kogan D., Blumberg S., Schieve L., et al. Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics 2009, 124:1395-1403.
5. Stokstad E. Development. New hints into the biological basis of autism. Science 1997, 36:1561-1569.
6. Boyle C., Boulet S., Schieve L., et al. Trends in the prevalence of developmental disabilities in US children, 1997-2008. Pediatrics 2011, 127:1034-1042.
7. Blumberg S.J., Bramlett M.D., Kogan M.D., et al. Change in the prevalence of parent-reported autism spectrum disorder in school-aged children: 2007 to 2011-2012. Natl Health Stat Rep 2013, 65:1-12.
8. Lakshmi Priya M.D., Geetha A. Level of trace elements (copper, zinc, magnesium and selenium) and toxic elements (lead and mercury) in the hair and nail of children with autism. Biol Trace Elem Res 2011, 142:148-158.
9. Clements C.J., McIntyre P.B. When science is not enough-a risk/benefit profile of thiomersal-containing vaccines. Expert Opin Drug Saf 2006, 5:17-29.
10. Lai M.C., Lombardo M.V., Baron-Cohen S. Autism. Lancet 2013, [Epub ahead of print] S0140-6736:61539-1.
11. Toriello H.V. Approach to the genetic evaluation of the child with autism. Pediatr Clin North Am 2012, 59:113-128.
12. Persico A.M., Napolioni V. Autism genetics. Behav Brain Res 2013, 251:95-112.
13. Silver W.G., Rapin I. Neurobiological basis of autism. Pediatr Clin North Am 2012, 59:45-61.
14. Courchesne E., Redcay E., Kennedy D.P. The autistic brain: Birth through adulthood. Curr Opin Neurol 2004, 17:489-496.
15. Pardo C.A., Vargas D.L., Zimmerman A.W. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry 2005, 17:485-495.
16. Zimmerman A.W., Jyonouchi H., Comi A.M., et al. Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol 2005, 33:195-201.
17. Chugani D.C. Neuroimaging and neurochemistry of autism. Pediatr Clin North Am 2012, 59:63-74.
18. Tareen R.S., Kamboj M.K. Role of endocrine factors in autism spectrum disorders. Pediatr Clin North Am 2012, 59:75-88.
19. Ghaziuddin M., Al-Owain M. Autism spectrum disorders and inborn errors of metabolism: An update. Pediatr Neurol 2013, 49:232-236.
20. Taanman J.W., Williams S.L. Structure and function of mitochondrial oxidative phosphorylation system. Mitochondrial Disorders in Neurology 2 2002, 1-34. Butterworth Heinemann, Boston. S. AH, S. DiMauro (Eds.).
21. Rossignol D.A., Frye R.E. Mitochondrial dysfunction in autism spectrum disorders: A systematic review and meta-analysis. Mol Psychiatr 2012, 17:290-314.
22. Dhillon S., Hellings J.A., Butler M.G. Genetic and mitochondrial abnormalities in autism spectrum disorders: A review. Curr Genomics 2011, 12:322-332.
23. Applegarth D.A., Toone J.R., Lowry R.B. Incidence of inborn errors of metabolism in British Columbia, 1969-1976. Pediatrics 2000, 105:e10.
24. Naviaux R.K. Developing a systematic approach to the diagnosis and classification of mitochondrial disease. Mitochondrion 2004, 4:351-361.
25. Elliott H.R., Samuels D.C., Eden J.A., et al. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 2008, 83:254-260.
26. Naviaux R.K. Mitochondria and autism spectrum disorders. The Neuroscience of Autism Spectrum Disorders 2013, 179-193. Academic Press, Amsterdam. B. JD, P.R. Hof (Eds.).
27. Coleman M., Blass J.P. Autism and lactic acidosis. J Autism Dev Disord 1985, 15:1-8.
28. László A., Horváth E., Eck E., et al. Serum serotonin, lactate and pyruvate in infantile autistic children. Clin Chim Acta 1994, 229:205-207.
29. Chugani D.C., Sundram B.S., Behen M., et al. Evidence of altered energy metabolism in autistic children. Prog Neuropsychopharmacol Biol Psychiatry 1999, 23:635-641.
30. Haas R.H. Autism and mitochondrial disease. Dev Disabil Res Rev 2010, 16:144-153.
31. Frye R.E., Rossignol D.A. Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatr Res 2011, 69:41R-47R.
32. Sue C.M., Bruno C., Andreu A.L., et al. Infantile encephalopathy associated with the MELAS A3243G mutation. J Pediatr 1999, 134:696-700.
33. Graf W.D., Marin-Garcia J., Gao H.G., et al. Autism associated with the mitochondrial DNA G8363A transfer RNA (Lys) mutation. J Child Neurol 2000, 15:357-361.
34. Filiano J.J., Goldenthal M.J., Rhodes C.H., et al. Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome. J Child Neurol 2002, 17:435-439.
35. Pons R., Andreu A.L., Checcarelli N., et al. Mitochondrial DNA abnormalities and autistic spectrum disorders. J Pediatr 2004, 144:81-85.
36. Weissman J.R., Kelley I.R., Bauman M.L., et al. Mitochondrial disease in autism spectrum disorder patients analysis. PLoS One 2008, 3:e3815.
37. Shoffner J., Hyams L., Niedziela G.N., et al. Fever plus mitochondrial disease could be risk factors for autistic regression. J Child Neurol 2010, 25:429-434.
38. Giulivi C., Zhang Y.F., Omanska-Klusek A., et al. Mitochondrial dysfunction in autism. J Am Med Assoc 2010, 304:2389-2396.
39. Napoli E., Wong S., Giulivi C. Evidence of reactive oxygen species-mediated damage to mitochondrial DNA in children with typical autism. Mol Autism 2013, 4:2.
40. Smith M., Spence M.A., Flodman P. Nuclear and mitochondrial genome defects in autisms. Ann N Y Acad Sci 2009, 1151:102-132.
41. Filipek P.A., Juranek J., Smith M., et al. Mitochondrial dysfunction in autistic patients with 15q inverted duplication. Ann Neurol 2003, 53:801-804.
42. Ramoz N., Reichert J.G., Smith C.J., et al. Linkage and association of the mitochondrial aspartate glutamate carrier SLC25A12 gene with autism. Am J Psychiatry 2004, 161:662-669.
43. Lepagnol-Bestel A.M., Maussion G., Boda B., et al. SLC25A12 expression is associated with neurite outgrowth and is upregulated in the prefrontal cortex of autistic subjects. Mol Psychiatry 2008, 13:385-397.
44. Segurado R., Conroy J., Meally E., et al. Confirmation of association between autism and the mitochondrial aspartate/glutamate carrier SLC25A12 gene on chromosome 2q31. Am J Psychiatry 2005, 162:2182-2184.
45. Silverman J.M., Buxbaum J.D., Ramoz N., et al. Autism-related routines and rituals associated with a mitochondrial aspartate/glutamate carrier SLC25A12. Am J Med Genet B Neuropsychiatr Genet 2008, 147:408-410.
46. Correia C., Coutinho A.M., Diogo L., et al. Brief report: High frequency of biochemical markers for mitochondrial dysfunction in autism: No association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. J Autism Dev Disord 2006, 36:1137-1140.
47. Chien W.H., Wu Y.Y., Gau S.S., et al. Association study of SLC25A12 gene and autism in Ham Chinese in Taiwan. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:189-192.
48. Marui T., Funatogawa I., Koishi S., et al. The NADH-ubiquinone oxidoreductase 1 alpha subcomplex 5 (NDUFA5) gene variants are associated with autism. Acta Psychiatr Scand 2011, 123:118-124.
49. Ezugha H., Goldenthal M., Valencia I., et al. 5q14.3 deletion manifesting as mitochondrial disease and autism: Case report. J Child Neurol 2010, 25:1232-1235.
50. Guevara-Campos J., González-Guevara L., Briones L., et al. Autism associated to a deficiency of complexes III and IV of the mitochondrial respiratory chain. Invest Clin 2010, 51:423-431.
51. Anitha A., Nakamura K., Thanseem I., et al. Brain region-specific altered expression and association of mitochondria-related genes in autism. Mol Autism 2012, 3:1-12.
52. Anitha A., Nakamura K., Thanseem I., et al. Downregulation of the expression of mitochondrial electron transport complex genes in autism brains. Brain Pathol 2013, 23:294-302.
53. Gu F., Chauhan V., Kaur K., et al. Alterations in mitochondrial DNA copy number and the activities of electron transport chain complexes and pyruvate dehydrogenase in the frontal cortex from subjects with autism. Transl Psychiatry 2013, 3:e299.
54. Oliveira G., Diogo L., Grazina M., et al. Mitochondrial dysfunction in autism spectrum disorders: A population-based study. Dev Med Child Neurol 2005, 47:185-189.
55. Poling J.S., Frye R.E., Shoffner J., et al. Developmental regression and mitochondrial dysfunction in a child with autism. J Child Neurol 2006, 21:170-172.
56. Clark-Taylor T., Clark-Taylor B.E. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial β-oxidation by long chain acyl-CoA dehydrogenase. Med Hypotheses 2004, 62:970-975.
57. Pastural E., Ritchie S., Lu Y., et al. Novel plasma phospholipid biomarkers of autism: Mitochondrial dysfunction as a putative causative mechanism. Prostaglandins Lekot Essent Fatty Acids 2009, 81:253-264.
58. Tsao C.Y., Mendell J.R. Autistic disorder in 2 children with mitochondrial disorders. J Child Neurol 2007, 22:1121-1123.
59. Goldenthal M.J., Shah N., Sheth S., et al. Buccal swab analysis reveals a high prevalence of mitochondria respiratory chain defects in children and adolescents with autism spectrum disorders. 40th Annual Meeting of the Child Neurology Society. Ann Neurol 2011, 70(Suppl 15):127. [abstract].
60. Goldenthal M.J., Kuruvilla T., Damle S., et al. Non-invasive evaluation of buccal respiratory chain enzyme dysfunction in mitochondrial disease: Comparison with studies in muscle biopsy. Mol Genet Metab 2012, 105:457-462.
61. Frye E.E. Mitochondrial disease in 22q13 duplication syndrome. J Child Neurol 2012, 27:942-949.
62. Craig A.K., Sotero de Menezes M., Sanetro R.P. Dravet syndrome: Patients with co-morbid SCN1A gene mutations and mitochondrial electron transport chain defects. Seizure 2012, 21:17-20.
63. Chauhan A., Gu F., Wegiel E.J., et al. Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J Neurochem 2011, 117:209-220.
64. Tang G., Gutierrez Rios P., Kuo S.H., et al. Mitochondrial abnormalities in temporal lobe of autistic brain. Neurobiol Dis 2013, 54:349-361.
65. Zhang Q., Raoof M., Chen Y., et al. Circulating mitochondrial DAMPS cause inflammatory responses to injury. Nature 2010, 464:104-107.
66. Cavalier-Smith T. Origin of mitochondria by intracellular enslavement of a photosynthetic purple bacterium. Proc Biol Sci 2006, 273:1943-1952.
67. West A.P., Shadel G.S., Ghosh S. Mitochondria in innate immune responses. Nat Rev Immunol 2011, 11:389-402.
68. Ashwood P., Anthony A., Torrente F., et al. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: Mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol 2004, 24:664-673.
69. Ashwood P., Wills S., Van de Water J. The immune response in autism: A new frontier for autism research. J Leukoc Biol 2006, 80:1-15.
70. Smith S.E., Li J., Garbett K., et al. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007, 27:10695-10702.
71. Careaga M., Ashwood P. Autism spectrum disorders: From immunity to behavior. Methods Mol Biol 2012, 934:219-240.
72. Psarra A.M., Solakidi S., Sekeris C.E. The mitochondrion as a primary site of action of regulatory agents involved in neuroimmunomodulation. Ann N Y Acad Sci 2006, 1088:12-22.
73. Psarra A.M., Sekeris C.E. Glucocorticoid receptors and other transcription factors in mitochondria and possible functions. Biochim Biophys Acta 2009, 1787:431-436.
74. Zecchini E., Siviero R., Giorgi C., et al. Mitochondrial calcium signalling: Message of life and death. Ital J Biochem 2007, 56:235-242.
75. Gellerich F.N., Gizatullina Z., Trumbeckaite S., et al. The regulation of OXPHOS by extramitochondrial calcium. Biochim Biophys Acta 2010, 1797:1018-1027.
76. Napolioni V., Persico A.M., Porcelli V., et al. The mitochondrial aspartate/glutamate carrier AGC1 and calcium homeostasis: Physiological links and abnormalities in autism. Mol Neurobiol 2011, 44:83-92.
77. Demaurex N., Poburko D., Frieden M. Regulation of plasma membrane calcium fluxes by mitochondria. Biochim Biophys Acta 2009, 1787:1383-1394.
78. Palmieri L., Persico A.M. Mitochondrial dysfunction in autism spectrum disorders: Cause or effect?. Biochim Biophys Acta 2010, 1797:1130-1137.
79. Rizzutto R., Bernardi P., Pozzan T. Mitochondria as all-round players of calcium game. J Physiol 2000, 520(Pt 1):37-47.
80. Tripathy P., Kashyap L., Singh V. The role of nitric oxide in inflammatory reactions. FEMS Immunol Med Microbiol 2007, 51:443-452.
81. Larbi A., Kempf J., Pawelec G. Oxidative stress modulation and T cell activation. Exp Gerontol 2007, 42:852-858.
82. Rubenstein J.L., Merzenich M.M. Model of autism: Increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2003, 2:255-267.
83. Anderson M.P., Hooker B.S., Herbert M.R. Bridging from cells to cognition in autism pathophysiology: Biological pathways to defective brain function and plasticity. Am J Biochem Biotechnol 2008, 4:167-176.
84. 2+ signaling. Curr Opin Neurobiol 2007, 17:112-119.
85. Palmieri L., Vapaleo V., Porcelli V., et al. Altered calcium homeostasis in autism-spectrum disorders: Evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. Mol Psychiatry 2010, 15:38-52.
86. Frye R.E., Delatorre R., Taylor H., et al. Redox metabolism abnormalities in autistic children associated with mitochondrial disease. Transl Psychiatry 2013, 3:e273.
87. Koopman W.J., Nijtmans L.G., Dieteren C.E., et al. Mammalian mitochondrial complex I: Biogenesis, regulation, and reactive oxygen species generation. Antioxid Redox Signal 2010, 12:1431-1470.
88. Chinta S.J., Andersen J.K. Nitrosylation and nitration of mitochondrial complex I in Parkinson's disease. Free Radic Res 2011, 45:53-58.
89. Ghanizadeh A. Targeting mitochondria by olesoxime or complement 1q binding protein as a novel management for autism: A hypothesis. Mol Syndromol 2011, 2:50-52.
90. James S.J., Rose S., Melnyk S., et al. Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells from children with autism. FASEB J 2009, 23:2374-23383.
91. Damodaran L.P., Arumugam G. Urinary oxidative stress markers in children with autism. Redox Rep 2011, 16:216-222.
92. Melnyk S., Fuchs G.J., Schulz E., et al. Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism. J Autism Dev Disord 2012, 42:362-377.
93. Rose S., Melnyk S., Pavliv O., et al. Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry 2012, 2:e134.
94. Naviaux R.K. Oxidative shielding or oxidative stress?. J Pharmacol Exp Ther 2012, 342:608-618.
95. Ristow M., Zarse K. How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis). Exp Gerontol 2010, 45:410-418.
96. Abbracchio M.P., Burnstock G., Verkhratsky A., et al. Purinergic signaling in the nervous system: An overview. Trends Neurosci 2009, 32:19-29.
97. Franke H., Sauer C., Rudolph C., et al. P2 receptor-mediated stimulation of the PI3-K/Akt-pathway in vivo. Glia 2009, 57:1031-1145.
98. Pelegrin P. Targeting interleukin-1 signaling in chronic inflammation: Focus on P2X(7) receptor and pannexin-1. Drug News Perspect 2008, 21:424-433.
99. Gallego D., Vanden Berghe P., Farre R., et al. P2Y1 receptors mediate inhibitory neuromuscular transmission and enteric neuronal activation in small intestine. Neurogastroenterol Motil 2008, 20:159-168.
100. Matos J.E., Sorensen M.V., Geyti C.S., et al. Distal colonic Na(+) absortion inhibited by luminal P2Y(2) receptors. Pflügers Arch 2007, 454:977-987.
101. Surprenant A., North R.A. Signaling at purinergic P2X receptors. Annu Rev Physiol 2009, 71:333-359.
102. Leng Y., Yamamoto T., Kadowaki M. Alteration of cholinergic, purinergic and sensory neurotransmission in the mouse colon of food allergy model. Neurosci Lett 2008, 445:195-198.
103. Housley G.D., Jagger D.J., Greenwood D., et al. Purinergic regulation of sound transduction and auditory neurotransmission. Audiol Neurootol 2002, 7:55-61.
104. Hall L., Kelley E. The contribution of epigenetics to understanding genetic factors in autism. Autism 2013, [Epub ahead of print].
105. Wallace D.C., Fan W. Energetics, epigenetics, mitochondrial genetics. Mitochondrion 2010, 10:12-31.
106. James S.J., Cutler P., Melnyk S., et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 2004, 80:1611-1617.
107. Naviaux R.K. Mitochondrial control of epigenetics. Cancer Biol Ther 2008, 7:1191-1193.
108. Patterson P.H. Modeling autistic features in animals. Pediatr Res 2011, 69(5 Pt2):34R-40R.
109. Grosser E., Hirt U., Janc O.A., et al. Oxidative burden and mitochondrial dysfunction in a mouse model of Rett syndrome. Neurobiol Dis 2012, 48:102-114.
110. Goto J., Talos D.M., Klein P., et al. Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. Proc Natl Acad Sci U S A 2011, 108:E1070-E1079.
111. Yao A., Jin S., Li X., et al. Drosophila FMRP regulates microtubule network formation and axonal transport of mitochondria. Hum Mol Genet 2011, 20:51-63.
112. Naviaux R.K., Zolkipli Z., Wang L., et al. Antipurinergic therapy corrects the autism-like features in the poly(IC) mouse model. PLoS One 2013, 8:e57380.